Profile for Spain Patent: 2687291
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Spain Patent: 2687291
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 9,868,745 | Nov 16, 2032 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
| 8,575,135 | May 16, 2033 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
| 8,575,135 | May 16, 2033 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
| 8,921,341 | May 16, 2033 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
| 8,921,341 | May 16, 2033 | Gilead Sciences Inc | VOSEVI | sofosbuvir; velpatasvir; voxilaprevir |
| 8,940,718 | May 16, 2033 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
